Calliditas Therapeutics AB American Depositary Shares (CALT)

CALT was delisted on the 20th of September, 2024.

• Market cap: $1.08B
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Calliditas Therapeutics AB is a commercial-stage biopharma company focused on identifying, developing, and commercializing novel treatments in orphan indications, initially focusing on renal and hepatic diseases with unmet medical needs. The company's pipeline candidate is TARPEYO medication to reduce proteinuria in IgA nephropathy.

Employees: 222